AngioDynamics Reports Fiscal 2019 Fourth Quarter and Full-Year Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/20/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- Far-left party wins Berlin election, pledging to nationalise housing
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Cybercrime feud erupts on dark web as notorious group claims hijack of rival's website
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
AngioDynamics (ANGO) Reports In-Line Q4 EPS, Offers FY20 Guidance
July 10, 2019 7:01 AM EDTAngioDynamics (NASDAQ: ANGO) reported Q4 EPS of $0.25, in-line with the analyst estimate of $0.25. Revenue for the quarter came in at $96.3 million versus the consensus estimate of $92.33 million.
GUIDANCE:
AngioDynamics sees FY2020 EPS of $0.25-$0.30, versus the consensus of $0.25. AngioDynamics sees... More
